DEA schedule
Is levetiracetam a controlled substance?
Federal schedule for levetiracetam from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Levetiracetam is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and levetiracetam is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted levetiracetam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 304 prescription listings from 90 labelers, none with a DEA schedule |
| DEA controlled substances list | levetiracetam is not on the list |
Levetiracetam NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 80705-100 | ELEPSIA XR 1000 MG | tablet, extended release | 1000 mg/1 | TRIPOINT THERAPEUTICS, LLC | None |
| 80705-101 | ELEPSIA XR 1500 MG | tablet, extended release | 1500 mg/1 | TRIPOINT THERAPEUTICS, LLC | None |
| 50474-002 | Keppra | injection, solution, concentrate | 100 mg/mL | UCB, Inc. | None |
| 50474-001 | Keppra | solution | 100 mg/mL | UCB, Inc. | None |
| 50474-597 | Keppra | tablet, film coated | 1000 mg/1 | UCB, Inc. | None |
| 50474-594 | Keppra | tablet, film coated | 250 mg/1 | UCB, Inc. | None |
| 50474-595 | Keppra | tablet, film coated | 500 mg/1 | UCB, Inc. | None |
| 50474-596 | Keppra | tablet, film coated | 750 mg/1 | UCB, Inc. | None |
| 50474-598 | Keppra XR | tablet, film coated, extended release | 500 mg/1 | UCB, Inc. | None |
| 50474-599 | Keppra XR | tablet, film coated, extended release | 750 mg/1 | UCB, Inc. | None |
| 44567-502 | Levetiracetam | injection | 10 mg/mL | WG Critical Care, LLC | None |
| 44567-502 | Levetiracetam | injection | 10 mg/mL | WG Critical Care, LLC | None |
| 67457-265 | Levetiracetam | injection | 10 mg/mL | Mylan Institutional LLC | None |
| 44567-503 | Levetiracetam | injection | 15 mg/mL | WG Critical Care, LLC | None |
| 67457-266 | Levetiracetam | injection | 15 mg/mL | Mylan Institutional LLC | None |
| 44567-501 | Levetiracetam | injection | 5 mg/mL | WG Critical Care, LLC | None |
| 44567-501 | Levetiracetam | injection | 5 mg/mL | WG Critical Care, LLC | None |
| 67457-255 | Levetiracetam | injection | 5 mg/mL | Mylan Institutional LLC | None |
| 43485-104 | Spritam | tablet, for suspension | 1000 mg/1 | Aprecia Pharmaceuticals, LLC | None |
| 43485-101 | Spritam | tablet, for suspension | 250 mg/1 | Aprecia Pharmaceuticals, LLC | None |
| 43485-102 | Spritam | tablet, for suspension | 500 mg/1 | Aprecia Pharmaceuticals, LLC | None |
| 43485-103 | Spritam | tablet, for suspension | 750 mg/1 | Aprecia Pharmaceuticals, LLC | None |
| 0264-1009 | Levetiracetam | injection | 10 mg/mL | B. Braun Medical Inc. | None |
| 36000-356 | levetiracetam | injection | 10 mg/mL | Baxter Healthcare Corporation | None |
| 43598-636 | Levetiracetam | injection | 10 mg/mL | Dr.Reddy's Laboratories Inc | None |
| 43598-757 | Levetiracetam | injection | 10 mg/mL | Dr.Reddy's Laboratories Inc | None |
| 65219-044 | Levetiracetam | injection | 10 mg/mL | Fresenius Kabi USA, LLC | None |
| 66298-0447 | Levetiracetam | injection | 10 mg/mL | Hp Halden Pharma AS | None |
| 68083-153 | Levetiracetam | injection | 10 mg/mL | Gland Pharma Limited | None |
| 0143-9574 | Levetiracetam | injection | 100 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0143-9673 | Levetiracetam | injection | 100 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 42571-331 | LEVETIRACETAM | injection | 100 mg/mL | Micro Labs Limited | None |
| 72485-106 | LEVETIRACETAM | injection | 100 mg/mL | Armas Pharmaceuticals Inc. | None |
| 72572-360 | Levetiracetam | injection | 100 mg/mL | Civica, Inc. | None |
| 65145-174 | Levetiracetam | injection | 1000 mg/100mL | Caplin Steriles Limited | None |
| 70069-846 | Levetiracetam | injection | 1000 mg/100mL | Somerset Therapeutics, LLC | None |
| 0264-1509 | Levetiracetam | injection | 15 mg/mL | B. Braun Medical Inc. | None |
| 36000-354 | levetiracetam | injection | 15 mg/mL | Baxter Healthcare Corporation | None |
| 43598-637 | Levetiracetam | injection | 15 mg/mL | Dr.Reddy's Laboratories Inc | None |
| 43598-759 | Levetiracetam | injection | 15 mg/mL | Dr.Reddy's Laboratories Inc | None |
Showing 40 of 304 listings.
Questions
Is levetiracetam a controlled substance?
No. Levetiracetam is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and levetiracetam is not on the DEA controlled substances list.
Is levetiracetam a narcotic?
No. Levetiracetam is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Levetiracetam
- What is Levetiracetam used for?FDA label uses
- Generic for KeppraFDA Orange Book
- Generic for Keppra XRFDA Orange Book
- Generic for SpritamFDA Orange Book
- What is Keppra used for?FDA label uses
- Is Keppra a controlled substance?Federal schedule
- NDC 43485-101Levetiracetam NDC record
- NDC 43485-102Levetiracetam NDC record
- NDC 43485-103Levetiracetam NDC record